CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
RNA-seq (gene expression) · human · 68 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 68 samples: 16 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradationSignal transduction and targeted therapy · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE252569_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1061199 and SRA study SRP481731. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 54 samples.
How we read this: 16 replicated groups read from 68 sample titles; they account for 54 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8003307 Control1 Control
- GSM8003308 Control2 Control
- GSM8003309 Control3 Control
- GSM8003310 Enzalutamide1 Enzalutamide
- GSM8003311 Enzalutamide2 Enzalutamide
- GSM8003312 Enzalutamide3 Enzalutamide
- GSM8003313 Simurosertib1 Simurosertib
- GSM8003314 Simurosertib2 Simurosertib
- GSM8003315 Simurosertib3 Simurosertib
- GSM8003316 Combo1 Combo
- GSM8003317 Combo2 Combo
- GSM8003318 Combo3 Combo
- GSM8003319 Control1 (dataset 2)
- GSM8003320 Control2 (dataset 2)
- GSM8003321 Control3 (dataset 2)
- GSM8003322 Control4 (dataset 2)
- GSM8003323 Enzalutamide1 (dataset 2)
- GSM8003324 Enzalutamide2 (dataset 2)
- GSM8003325 Enzalutamide3 (dataset 2)
- GSM8003326 Enzalutamide4 (dataset 2)
- GSM8003327 Simurosertib1 (dataset 2)
- GSM8003328 Simurosertib2 (dataset 2)
- GSM8003329 Simurosertib3 (dataset 2)
- GSM8003330 Combo1 (dataset 2)
- GSM8003331 Combo2 (dataset 2)
- GSM8003332 Combo3 (dataset 2)
- GSM8003333 H146-Cis1 H146-Cis
- GSM8003334 H146-Cis2 H146-Cis
- GSM8003335 H146-Cis4 H146-Cis
- GSM8003336 H146-Comb1 H146-Comb
- GSM8003337 H146-Comb2 H146-Comb
- GSM8003338 H146-Comb3 H146-Comb
- GSM8003339 H146-Comb4 H146-Comb
- GSM8003340 H146-Ctrl1 H146-Ctrl
- GSM8003341 H146-Ctrl2 H146-Ctrl
- GSM8003342 H146-Ctrl3 H146-Ctrl
- GSM8003343 H146-Ctrl4 H146-Ctrl
- GSM8003344 H146-Sim1 H146-Sim
- GSM8003345 H146-Sim2 H146-Sim
- GSM8003346 H146-Sim3 H146-Sim
+ 28 more — browse all 68 samples with per-sample file links →
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE323983 Senescence inhibition by rapamycin mitigates radiation-induced atherosclerotic characteristics in human coronary endothelial cells 23 samples shares myc, inhibition
- GSE306800 Extracellular matrix-myCAF signatures correlate with resistance to neoadjuvant aPD-L1 immune checkpoint inhibition with durvalumab + metformin in HPV+ HNSCC 18 samples shares myc, inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.